| Dr Edward Stephen Lim, MD | |
|
144 N Main St, Branford, CT 06405-3044 | |
| (203) 643-0270 | |
| (203) 488-1104 |
| Full Name | Dr Edward Stephen Lim |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 144 N Main St, Branford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124099726 | NPI | - | NPPES |
| 001337105 | Medicaid | CT | |
| D400003711 | Other | CT | MEDICARE PTAN |
| 010033710CT09 | Other | CT | ANTHEM |
| 180034796 | Other | CT | MC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 033710 (Connecticut) | Primary |
| Entity Name | Edward S Lim, Md, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770710220 PECOS PAC ID: 6800941931 Enrollment ID: O20090929000126 |
News Archive
Drugmaker Merck & Co. Inc. on Thursday said its investigational vaccine against a sexually transmitted virus linked to cervical cancer triggered a stronger immune response in young adolescents than in young women in a late-stage trial.
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.
There are many obstacles to diagnosing and effectively treating hereditary angioedema (HAE). Symptoms of HAE are often indistinguishable from other conditions and accurate diagnosis requires both detailed patient and family history, as well as a combination of laboratory tests.
The risk of cardiovascular sudden death was very small and only about 30% of the incidence were due to diseases that could be reliably detected by pre-participation screening, even with 12-lead ECGs, according to research in a U.S. high school athlete population presented March 10 at the American College of Cardiology (ACC) Scientific Sessions.
Today's headlines include reports about how the presidential election's outcome could impact the insurance industry as well as the fate of people who are sick or uninsured.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Stephen Lim, MD 144 N Main St, Branford, CT 06405-3044 Ph: (203) 643-0270 | Dr Edward Stephen Lim, MD 144 N Main St, Branford, CT 06405-3044 Ph: (203) 643-0270 |
News Archive
Drugmaker Merck & Co. Inc. on Thursday said its investigational vaccine against a sexually transmitted virus linked to cervical cancer triggered a stronger immune response in young adolescents than in young women in a late-stage trial.
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.
There are many obstacles to diagnosing and effectively treating hereditary angioedema (HAE). Symptoms of HAE are often indistinguishable from other conditions and accurate diagnosis requires both detailed patient and family history, as well as a combination of laboratory tests.
The risk of cardiovascular sudden death was very small and only about 30% of the incidence were due to diseases that could be reliably detected by pre-participation screening, even with 12-lead ECGs, according to research in a U.S. high school athlete population presented March 10 at the American College of Cardiology (ACC) Scientific Sessions.
Today's headlines include reports about how the presidential election's outcome could impact the insurance industry as well as the fate of people who are sick or uninsured.
› Verified 1 days ago